Psychotropic drug interactions with valproate

Clinical Neuropharmacology

Volumn 28, Issue 2, 2005, Pages 96-101

  Fleming, Jessica ^a   Chetty, Manoranjenni ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Drug interactions; Psychotropic drugs; Valproic acid

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; MOCLOBEMIDE; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; ZIPRASIDONE; ZONISAMIDE;

AGITATION; APNEA; ATAXIA; BIPOLAR DISORDER; BRAIN INJURY; CLINICAL TRIAL; COMA; CONFUSION; DEMENTIA; DIPLOPIA; DROWSINESS; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG SAFETY; EPILEPSY; FATIGUE; HALLUCINATION; HEAD INJURY; HEADACHE; HUMAN; IMPULSIVENESS; MANIA; MENTAL DEFICIENCY; NYSTAGMUS; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RASH; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TACHYCARDIA; TOXIC EPIDERMAL NECROLYSIS; URINE RETENTION; VOMITING;

ANTICONVULSANTS; ARYL HYDROCARBON HYDROXYLASES; DRUG INTERACTIONS; HUMANS; PSYCHOTROPIC DRUGS; VALPROIC ACID;

EID: 16344384706     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000154221.37887.73     Document Type: Review

References (33)

1. Strain JJ, Chiu NM, Sultana K, et al. Psychotropic drug versus psychotropic drug: update. Gen Hosp Psychiatry. 2004;26:87-105.
2. Karow A, Lambert M. Polypharmacy in treatment with psychotropic drugs: the underestimated phenomenon. Curr Opin Psychiatry. 2003;16:713.
3. Zarate CA Jr, Quiroz JA. Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disord. 2003;5:217-225.
4. Post RM, Ketter TA, Pazzaglia PJ, et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl. 1996;11:153-180.
5. Mula M, Monaco F. Antiepileptic-antipsychotic drug interactions: a critical review of the evidence. Clin Neuropharmacol. 2002;25:280-289.
6. Schatzberg AF, Nemeroff CB. Essentials of Clinical Psychopharmacology. Washington, DC: American Psychiatric Press, 2001.
7. Alao AO. The frontier of mood stabilizers in psychiatry. Psychiatric Times [serial online]. 2002; 14(5). Available at www.psychiatrictimes.com/ accessed July 28, 2004.
8. Chen LC, Chou MH, Lin MF, et al. Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae radix, in healthy volunteers. J Clin Pharm Ther. 2000;25:453-459.
9. Patsalos PN, Froscher W, Pisani F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43:365-385.
10. Liston HL, Markowitz JS, DeVane CL. Drug glucuronidation in clinical psychopharmacology. J Clin Psychopharmacol. 2001;21:500-515.
11. Tanaka E. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther. 1998;23:403.
12. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol. 1995;15:387-398.
13. Brosen K. Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. Ther Drug Monit. 1996;18:393-396.
14. Rasmussen BB, Brosen K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Ther Drug Monit. 2000;22:143-154.
15. Taylor D, Lader M. Cytochromes and psychotropic drug interactions. [see comment] Br J Psychiatry. 1996;168:529.
16. Tanaka E, Hisawa S. Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther. 1999;24:7.
17. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2003;2:473-481.
18. Kando JC, Tohen M, Castillo J, et al. Concurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry. 1994;55:255-257.
19. Costello LE, Suppes T. A clinically significant interaction between clozapine and valproate. J Clin Psychopharmacol. 1995;15:139-141.
20. Longo LP, Salzman C. Valproic acid effects on serum concentrations of clozapine and norclozapine. Am J Psychiatry. 1995;152:650.
21. Facciola G, Avenoso A, Scordo MG, et al. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit. 1999;21:341-345.
22. Finley P, Warner D. Potential impact of valproic acid therapy on clozapine disposition. Biol Psychiatry. 1994;36:487-488.
23. Ishizaki T, Chiba K, Saito M, et al. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients. J Clin Psychopharmacol. 1984;4:254.
24. DeVane CL, Nemeroff CB. An evaluation of risperidone drug interactions. J Clin Psychopharmacol. 2001;21:408-416.
25. Janicak PG. The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics. J Clin Psychiatry. 1993;54(Suppl):35-41.
26. Monaco F, Cicolin A. Interactions between anticonvulsant and psychoactive drugs. Epilepsia. 1999;40(Suppl 10):71-76.
27. Tanaka E. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther. 1999;24:87.
28. Lindenmayer JP, Kotsaftis A. Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry. 2000;61:123-128.
29. Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia. 2002;43(Suppl 2):37-44.
30. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: General features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347-356.
31. Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berl). 2000;150:15-23.
32. Dunner DL. Drug interactions of lithium and other antimanic/mood- stabilizing medications. J Clin Psychiatry. 2003;64(Suppl 5):38-43.
33. Caraco Y. Genetic determinants of drug responsiveness and drug interactions. Ther Drug Monit. 1998;20:517-524.